Table: Solasia Pharma -2024 group forecast(IFRS)
Dec 27 (Reuters) -
Solasia Pharma K. K.
CONSOLIDATED EARNINGS ESTIMATES
(in billions of yen unless specified)
Full Year to Full Year to
Dec 31, 2024 Dec 31, 2024
LATEST PREVIOUS
FORECAST FORECAST
Sales 160 mln
Operating loss 1.15
PreTax loss 1.15
Net loss 1.15
EPS Basic loss 5.79 yen
NOTE - Solasia Pharma K. K..(Figures are reported based on international accounting rules (IFRS).)
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4597.T